Analyst Price Targets — CTIC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| September 1, 2022 5:05 am | Kelly Shi | Jefferies | $13.00 | $6.28 | TheFly | CTI BioPharma initiated with a Buy at Jefferies |
| August 9, 2022 9:23 am | — | JMP Securities | $9.00 | $6.59 | Benzinga | JMP Securities Maintains Market Outperform on CTI BioPharma, Raises Price Target to $9 |
| August 9, 2022 6:42 am | — | Needham | $9.00 | $7.06 | Benzinga | Needham Maintains Buy on CTI BioPharma, Raises Price Target to $9 |
| April 19, 2022 3:44 pm | Leah Rush Cann | DNB Markets | $12.00 | $4.73 | Pulse 2.0 | CTI BioPharma (CTIC) Stock: Why The Price Increased Over 9% Today |
| March 3, 2022 12:00 am | Robert Hazlett | BTIG | $9.00 | $3.95 | Pulse 2.0 | CTI BioPharma (CTIC) Stock: $9 Price Target And Buy Rating |
No recent news available for CTIC.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CTIC.
U.S. House Trading
No House trades found for CTIC.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.